Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2809)	2/6/2001 8:57:36 PM
From: Oak Tree	Respond to of 52153

Yes, the results are also in the New England J Med two weeks ago. Pritty good eg. NOVT is doing quite well, though I've been trader of the stock rarely keeping it for long periods. Paul

To: Jibacoa who wrote (2809)	3/3/2001 5:00:16 PM
From: Oak Tree	Read Replies (3) \| Respond to of 52153

Just a heads up. The sales reps at NOVT seem mighty happy. They are paid heavily in stock, though they probably don't really know any results. Specifically, the results of the non-stent trial will be coming out soon. If they outperform stents, many places could start using radiation instead of stents. This would be good for NOVT over the short run though they would have competition around the corner with the afterloading systems. The stock made a substantial jump on Friday. I wonder if info is on the street. I missed getting any shares. I think I'll hope for a pullback Monday and get back in.